1º Cátedra de Clínica Médica y Terapéutica. UNR. | 08 OCT 12
La resolución del caso! ¿Cuál es su diagnóstico? XXIII
Se presenta el caso de una mujer de 20 años con fiebre, cefalea, diarrea y dolor abdominal. Los invitamos a dejar sus comentarios y posibles diagnósticos en el sector comentarios.
169
19
INDICE:  1. La resolución del caso | 2. Caso Clínico | 3. Referencias
Referencias

Bibliografía
1- Kapperud, G. Yersinia enterocolitica in foodhygiene. Int  J Food Microbiol 1991; 12:53.
2- Nuorti JP, Niskanen T, Hallanvuo S, et al. A wide spread outbreak of Yersinia pseudotuberculosis. J Infect Dis 2004; 189:766.
3- Tacket CO, Davis BR, Carter GP, et al. Yersinia enterocolitica pharyngitis. Ann InternMed 1983; 99:40.
4- Parry CM, Hien TT, Dougan G, et al. Typhoidfever. N Engl J Med 2002; 347:1770.
5- Gasem M, Dolmans WM, Isbandrio B, et al. Culture of Salmonella typhi and Salmonella paratyphi fromblood and bonemarrow in suspected typhoid fever. Trop Geogr Med 1995; 47:164.
6- Skirrow MB, Blaser MJ. Campylobacter jejuni. In: Infections of the gastrointestinal tract, 2nd ed, Blaser, MJ, Smith, PD, Ravdin, JI, et al (Eds), Lippincott Williams and Wilkins, Philadelphia, 2002. p. 719.
7- Pacanowski J, Lalande V, Lacombe K, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis 2008; 47:790
8- Horvath KD, Whelan RL. Intestinal tuberculosis: Return of an old disease. Am J Gastroenterol 1998; 93:692.
9- Suri S, Gupta S, Suri R. Computed tomography in abdominal tuberculosis. Br J Radiol 1999; 72:92.
10- Pulimood AB, Ramakrishna BS, Kurian G, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 1999; 45:537.
11-  Fauci, Braunwald, Kasper, Hauser, Longo, Jamesosn, Loscalzo.Harrison Medicina Interna.17 edición.2009;289:1890-1894.
12-  Pimentel M, Chang M, Chow EJ, et al. Identification of a prodromalperiod in Crohn's disease but not ulcerative colitis. Am J Gastroenterol 2000; 95:3458.
13- Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis—how much is irritable bowe lsyndrome?.Clin GastroenterolHepatol 2006; 4:614.
14- Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn'sdisease. Eur Radiol 2008; 18:438.
15- Lin MF, Narra V. Developing role of magnetic resonance imaging in Crohn's disease. Curr Opin Gastroenterol 2008; 24:135.
16- Fidler J. MR imaging of thesmallbowel. RadiolClin North Am 2007; 45:317.
17- Dotan I. Serologicmarkers in inflammatory bowel disease: tools for better diagnosis and disease stratification. Expert Rev Gastroenterol Hepatol 2007; 1:265.
18- Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96:730.
19- Anand V, Russell AS, Tsuyuki R, Fedorak R.Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies asserologicalmarkers are notspecific in the identification of Crohn’s disease and ulcerative colitis. Can J Gastroenterol. 2008 Jan;22(1):33-6.
20- Quinton J et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.Gut. 1998 Jun;42(6):788-91.
21- Buckland M,  Mylonaki M,  Rampton D, Longhurst J. Serological Markers (Anti-Saccharomyces cerevisiae Mannan Antibodies and Antineutrophil Cytoplasmic Antibodies) in Inflammatory Bowel Disease: Diagnostic Utility and Phenotypic Correlation. ClinDiagn Lab Immunol. 2005 Nov;12(11):1328-30.
22- Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:661.
23- Chamouard P, Richert Z, Meyer N, et al. Diagnostic Value of C-Reactive Protein for Predicting Activity Level of Crohn's  Disease. Clin Gastroenterol Hepatol 2006; 4:882.
24- Fauci, Braunwald, Kasper, Hauser, Longo, Jamesosn, Loscalzo.Harrison Medicina Interna.17 edición.2009;87:578-579.
25- Fauci, Braunwald, Kasper, Hauser, Longo, Jamesosn, Loscalzo.Harrison Medicina Interna.17 edición.2009;105:694-695.
26- Devaney K, Jaffe ES. The surgicalpathology of gastrointestinal Hodgkin'sdisease. Am J ClinPathol 1991; 95:794.
27- Palli D, Trallori G, Bagnoli S, et al. Hodgkin's disease increased in patients with ulcerative colitis. Gastroenterology 2000; 119:647.
28- Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-hodgkin'slymphoma: i. anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the german multicenter study gitnhl 01/92. J ClinOncol 2001; 19:3861.
29- Papaxoinis G, Papageorgiou S, Rontogianni D, et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). LeukLymphoma 2006; 47:2140.
30- Lewis JD, BilkerWB, Brensinger C, et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001; 121:1080.

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí